Skip to main content
. 2020 Sep 30;15(9):e0239606. doi: 10.1371/journal.pone.0239606

Table 1. Baseline characteristics of the 200 patients included.

Characteristics No. (%) or Median |IQR]
All patients (n = 200 unless stated) Pneumonia excluded (n = 67) Pneumonia confirmed (n = 133)
Demographics
 Age (years) 84 [79–90] 86 [80–92] 83 [78–89]
 Female gender 98 (49.0) 38 (56.7) 60 (45.1)
 Active smoker, n(%) (n = 199) 34 (17.0) 7 (10.4) 27 (20.3)
 Living place
  Home 172 (86.0) 55 (82.1) 117 (88.0)
  Nursing home 21 (10.5) 10 (15.0) 11 (8.3)
  Other 7 (3.5) 2 (2.9) 5 (3.7)
Comorbidities
 Cardiovascular disease 103 (51.5) 37 (55.2) 66 (49.6)
 Chronic obstructive pulmonary disease (n = 197) 35 (17.8) 9 (13.4) 26 (20.0)
 Chronic renal disease 60 (30.0) 24 (35.8) 36 (27.1)
 Cerebrovascular disease 31 (15.5) 11 (16.4) 20 (15.0)
 Immunosuppressive therapy (n = 199) 15 (7.5) 3 (4.5) 12 (9.0)
 Diabetes mellitus 45 (22.5) 13 (19.4) 32 (24.1)
 Chronic liver disease 11 (5.5) 3 (4.5) 8 (6.0)
 Active cancer (n = 196) 17 (8.7) 3 (4.6) 14 (10.7)
 Swallowing disorders (n = 177) 28 (15.8) 9 (14.1) 19 (16.8)
 Poor oral health (n = 175) 38 (21.7) 11 (19.0) 27 (23.1)
 Cognitive impairment (n = 193) 66 (34.5) 27 (42.2) 39 (30.7)
Scores
Charlson comorbidity index (n = 165)
 Mean 3 (1–10) 3 (1–10) 3 (1–9)
 Score = 1, n(%) 39 (23.6) 14 (25.5) 25 (22.7)
 Score = 2, n(%) 44 (26.7) 16 (29.1) 28 (25.5)
 Score >2, n(%) 82 (49.7) 30 (45.4) 57 (51.8)
Mini mental state examination n = 162) 24 (19–27) 22 (15–27) 24 (19–27)
Mini nutritional assessment (n = 178) 8 (6–11) 8 (6–10) 9 (6–11)
Symptoms and signs at admission
 Confusion 92 (46.0) 32 (47.8) 60 (45.1)
 Falls 71 (35.5) 29 (43.3) 42 (31.6)
 Respiratory rate >20/min 158 (79.4) 49 (73.1) 109 (82.6)
 Fever (temperature >37.8 °C) 103 (51.5) 29 (43.3) 84 (55.6)
 Cough 170 (85.0) 50 (74.6) 120 (90.2)
 Sputum production 74 (37.0) 25 (37.3) 49 (36.8)
 Chest pain 35 (17.5) 9 (13.4) 26 (19.5)
 Dyspnea 145 (72.5) 50 (74.6) 95 (71.4)
 Crackles 171 (85.5) 57 (85.1) 114 (85.7)
 Oxygen saturation <90% 102 (51.0) 30 (44.8) 72 (54.1)
 Pulse rate >125/min 13 (6.5) 6 (8.9) 7 (5.3)
 SBP <90 mmHg or DBP < …60 mmHg 34 (17.0) 10 (14.9) 24 (18.0)
Laboratory findings
 Leukocytes (103 per mm3) 11.0 [8.2–14.0] 10.7 [7.9–13.1] 11.3 [8.6–14.7]
 Urea (mg.L-1) 7.9 [6.0–11.9] 8.3 [6.2–12.8] 7.7 [5.7–10.8]
 NT-proBNP (ng.L-1) 1836.5 [666.8–3800.8] 1884.0 [649.5–3550.0] 1826.0 [685.5–3860.5]
 Prealbumin (g.L-1) 122.0 [95.0–162.0] 131.0 [99.0–167.0] 118.5 [86.7–157.2]
 Albumin (g.L-1) 35.0 [32.0–38.0] 35.0 [32.0–37.0] 35.0 [31.0–38.0]
 C-reactive protein (mg.L-1) 84.0 [45.8–159.7] 62.7 [38.5–107.5] 100.7 [59.0–205.2]
 Procalcitonin (μg.L-1) 0.3 [0.1–1.3] 0.2 [0.1–0.7] 0.4 [0.1–1.9]
 Serum amyloid A (μg.L-1) 265.0 [247.8–285.2] 262.0 [231.8–278.0] 267.5 [252.0–287.8]
 Neopterin (nmol.L-1) 7.6 [4.7–13.4] 9.3 [5.9–14.0] 6.6 [4.5–12.6]
Pathogen identified, n(%)
 Bacterial 22 (11.0) 4 (6.0) 18 (32.7)
 Viral 62 (31.0) 25 (37.3) 37 (67.3)
 None 116 (58.0) 38 (56.7) 78 (58.6)
Vaccination status, n(%)
 Influenza vaccination (n = 182) 103 (56.6) 36 (63.2) 67 (53.6)
 Pneumococcal vaccination (n = 177) 7 (3.9) 2 (3.6) 5 (4.1)
Disease severity, n(%)
 PSI score 102 [87–121] 104 [87–121] 98 [86–121]
 CURB 65 2 [2–3] 2 [2–3] 2 [2–3]
 CURB 65 >2 89 (44.5) 28 (41.8) 61 (45.9)
Outcome
 30-day mortality 14 (7.0) 4 (6.0) 10 (7.5)
 90-day mortality (n = 198) 29 (14.6) 10 (14.9) 19 (14.3)

Laboratory values and vital signs were obtained at hospital admission.

Definitions: Immunosuppressive therapy: prednisone for more than two weeks; or receipt of other immunosuppressive drugs. Cognitive impairment was diagnosed after geriatrician evaluation (at least CDR 1 dementia). Swallowing disorders: observed during the hospitalization

Oral health rated as good, medium or poor

Abbreviations: CURB65 is a pneumonia severity score based on confusion, respiratory rate, blood pressure, and age 65 or older. DBP: diastolic blood pressure SBP: systolic blood pressure